Clinical Trials Logo

Heart Valve Diseases clinical trials

View clinical trials related to Heart Valve Diseases.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 4

NCT ID: NCT02700581 Not yet recruiting - Clinical trials for Valvular Heart Disease

Impact of Positive End-expiratory Pressure on Hepatic Venous Flow

Start date: March 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the difference in the impact of moderate positive end-expiratory pressure (PEEP) on hepatic venous flow Doppler in patients undergoing cardiac surgery: conventional versus protective ventilation strategy The possible changes in forward and backward flows (Doppler profiles) of hepatic venous flow at different degrees of PEEP in conventional and protective ventilation strategies are analyzed by using intraoperative transesophageal echocardiography (TEE) in patients undergoing cardiac surgery .

NCT ID: NCT02623907 Not yet recruiting - Clinical trials for Aortic Valve Stenosis

China Valve Registry Study-1

CHIVAS-1
Start date: May 2016
Phase: N/A
Study type: Observational [Patient Registry]

With the aging of Chinese population, degenerative valvular disease is becoming more and more frequent, which has brought a heavy burden to our society. Taking aortic stenosis (AS) as an example, the incidence of AS in population over the age of 65 are about 2%, and in population above the age of 85 can be amounted to 4-8%, in the Western country. Since the invention of transcatheter aortic valve replacement (TAVR),aortic valve disease (AVD),including AS and aortic regurgitation (AR), has attracted more and more attention. To date, there are few data about the prevalence of AVD in China. The characteristics and prognosis of AVD in China are still unknown. Therefore, the investigators design a prospective, observational cohort study to investigate characteristics, treatments and prognosis of AVD in Chinese elderly population. The results of the study will provide a basis for the future national health policy for prevention and treatment of AVD in the elderly.

NCT ID: NCT02541877 Not yet recruiting - Clinical trials for Aortic Valve Stenosis

Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve

START
Start date: September 2015
Phase: Phase 3
Study type: Interventional

To observe the clinical outcomes of the different valve sizing strategies treating type-0 Bicuspid Aortic Stenosis (BAS) with self-expandable transcatheter aortic valve implantation (TAVI) valve, compared with those of a standard sizing strategy of normal Tricuspid Aortic Stenosis(TAS).

NCT ID: NCT02221921 Not yet recruiting - Clinical trials for Aortic Valve Stenosis

Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI

Start date: September 2014
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of the MicroPort's Valve and delivery system for transcatheter aortic valve implantation (TAVI) in severe aortic stenosis who are considered unsuitable for Surgical Valve Replacement.

NCT ID: NCT01409525 Not yet recruiting - Clinical trials for Coronary Artery Bypass Surgery Patients

Rate of Microbial Colonization Over Native Calcified Cardiac Valves

Start date: August 2011
Phase: N/A
Study type: Observational

The purpose of this observational, exploratory study in patients undergoing any cardiac valve replacement or repair is to assess the rate of bacterial colonization over native degenerative calcified cardiac valves.

NCT ID: NCT00641290 Not yet recruiting - Clinical trials for Ischemic Heart Disease

Vigileo FloTrac vs Pulmonary Artery Catheter

Start date: April 2008
Phase: N/A
Study type: Observational

To study the role of Vigileo monitor using the FloTrac sensor to measure cardiac output using the pulse contour analysis as well as central venous oxygen saturation monitoring as a guide for tissue perfusion. The accuracy of the Vigileo monitoring was compared with the conventional thermodilution method for measuring cardiac output using the pulmonary artery catheter and mixed venous oxygen saturation for assessing global tissue perfusion.